Behavioral treatment of insomnia in active-duty service members with traumatic brain injury: study protocol for a randomized clinical trial.
Anne Germain, Megan Wolfson, Emmanuel Espejo...
https://pubmed.ncbi.nlm.nih.gov/41630034/Actively Recruiting
Led by Noctem, LLC · Updated on 2025-04-24
168
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating Cognitive Behavioral Therapy for Insomnia CBT-I in active-duty sailors who have experienced traumatic brain injury TBI. The study aims to compare the effects of traditional in-person CBT-I and CBT-I delivered through a digital health platform called Clinician Operated Assistive Sleep Technology COAST against usual treatment on symptoms of insomnia, post-concussive effects, psychological health, and brain function. Participants will be assessed before treatment, after treatment, and three months later to understand the therapies impacts. The study involves three groups one receiving in-person CBT-I at a TBI clinic or via telehealth, another receiving CBT-I remotely through the COAST digital platform, and a third group receiving treatment as usual without insomnia-specific care. Both CBT-I interventions last six weeks and are delivered by doctoral-level clinicians. Participants in all groups will use the COAST app to complete daily sleep logs and assessments throughout the study. Participants will attend baseline and follow-up appointments where various questionnaires and inventories will be completed to measure insomnia severity, post-concussion symptoms, psychological conditions like PTSD, depression, anxiety, fatigue, and disability. Sleep diaries will be kept daily during the intervention and for one week before the follow-up visit. Medication use and sleep apnea therapy stability will be monitored, and assessments will occur at multiple time points including baseline, mid-treatment, post-treatment, and three months after treatment ends. The total participation duration spans from initial evaluation through the 3-month follow-up.
CONDITIONS
Behavioral Treatment of Insomnia in Active-Duty Service Members With Traumatic Brain Injury
A
Anne Germain, PhD
A
Anice Byrd
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Noctem, LLC
Lead Sponsor
Naval Health Research Center
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | In‑Person CBT‑I (6‑week behavioral therapy) | CBT‑I via COAST (6‑week digital platform) | Treatment as Usual (no behavioral intervention) |
|---|---|---|---|
| What it is | A 6‑week cognitive behavioral therapy for insomnia delivered in person by a doctoral‑level clinician. | A 6‑week cognitive behavioral therapy for insomnia delivered remotely via a clinician‑supervised digital platform. | Participants receive usual care without a structured behavioral insomnia intervention. |
| Role in trial | Investigational arm receiving in‑person delivery of CBT‑I. | Investigational arm receiving CBT‑I via a digital delivery platform. | Comparator arm representing usual care without structured behavioral treatment. |
| Primary use | Behavioral insomnia therapy using standard face‑to‑face delivery. | Behavioral insomnia therapy using a remote digital platform (COAST). | Standard care without structured CBT‑I intervention. |
| How it is given or performed | Delivered in person or via telehealth by a doctoral‑level clinician. | Delivered remotely via clinician‑supervised digital platform. | No behavioral therapy is delivered. |
| Evidence status | Cognitive behavioral therapy for insomnia is strongly recommended as first‑line treatment for chronic insomnia and supported in individuals with brain injury including TBI. | Remote delivery of CBT‑I via digital platforms shows promise and may be broadly effective, though direct evidence in TBI populations remains limited. | Usual care without structured behavioral treatment generally yields lesser improvements in insomnia symptoms compared with CBT‑I interventions. |
| Important risks | Behavioral treatment may involve temporary sleep restriction and stimulus control which can be tiring or challenging; risks are low. | Remote behavioral delivery may pose similar minimal risks related to sleep restriction and adherence challenges. | No added intervention‑related risks. |
| Important limitations | Applicability limited to active‑duty Navy servicemembers with TBI who own a smartphone; findings may not generalize to civilians or other military populations. | Digital delivery requires technology access and comfort; efficacy in broader or less tech‑savvy populations is uncertain. | Usual care lacks structured behavioral treatment and may include varied informal approaches to insomnia management. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 weeks
Participants receive 6 weeks of cognitive behavioral therapy for insomnia (CBT-I) either in-person or remotely via a digital platform, led by a doctoral-level clinician.
Weekly visits during the 6-week treatment period
Duration - 3 months post-treatment
Participants are followed up to assess insomnia severity and other health outcomes after completing treatment.
1 follow-up visit at 3 months post-treatment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Anne Germain, Megan Wolfson, Emmanuel Espejo...
https://pubmed.ncbi.nlm.nih.gov/41630034/Noctem, LLC
Lead Sponsor
Naval Health Research Center
Collaborating Sponsor